OFATUMUMAB is MORE effective than TERIFLUNOMIDE in MULTIPLE SCLEROSIS


OFATUMUMAB is MORE EFFECTIVE than TERIFLUNOMIDE in MULTIPLE SCLEROSIS Multiple sclerosis (MS) is an autoimmune demyelinating disorder affecting optic nerves, brain and spinal cord. Treatment includes disease modifying treatments (DMTs) to reduce the number of relapses. In a recent study, ofatumumab was compared with teriflunomide in patients with relapsing remitting multiple sclerosis. Ofatumumab is anContinue reading “OFATUMUMAB is MORE effective than TERIFLUNOMIDE in MULTIPLE SCLEROSIS”